Medical News

RSS

Dove Medical Press, Athena Healthcare Consultancy enter alliance to publish clinical research

Dove Medical Press, a leading open-access publisher, has entered into an alliance with Athena Healthcare Consultancy, a well established CRO and pharmaceutical medical marketing consultancy based in Shanghai.

16 Mar 2010

Tel Aviv University researcher uses magic tricks to treat children with locomotor disabilities

It's often hard to motivate youngsters with physical disabilities. But a new approach from a Tel Aviv University researcher bridges the worlds of behavior and science to help kids with paralysis and motor dysfunction improve their physical skills and inner confidence -- using a trick up her sleeve called "magic."

16 Mar 2010

Clinton delivers speech at U.N. women's meeting as conference closes

"Calling the subjugation of women a threat to American security, U.S. Secretary of State Hillary [Rodham] Clinton made a vibrant plea to give equal rights to women around the world," during a speech a the U.N. on Friday, Agence France-Presse reports.

16 Mar 2010

New guidelines to emphasize safety of dental treatment during pregnancy

Spotlighting the importance of oral health care for expectant mothers, the California Dental Association Foundation has released new guidelines designed to emphasize the safety of dental treatment during pregnancy and ensure women the services they need.

16 Mar 2010

GAVI calls meeting with existing, potential donors

The GAVI Alliance has "asked existing and potential donors to a meeting in The Hague on March 25 and 26 to challenge them to 'make a strong impact' on childhood death rates," Reuters reports. "GAVI, which is supported by the World Health Organization, the World Bank, UNICEF, the Bill & Melinda Gates Foundation and vaccine makers, says it has 40 percent of the $7 billion it needs between now and 2015 to help" immunize of millions of children in developing countries by 2015, according to the news service.

16 Mar 2010

KHN column: Can incremental health reform provide a path forward?

In this Kaiser Health News column, Gail Wilensky writes: "As we await another historic vote in the House on whether lawmakers will support the Senate version of reform, it's worth asking whether incremental reform would have been a better path" (3/15).

16 Mar 2010

Elmora Healthcare selects Authentidate's Inscrybe Healthcare for expediting care order processing

Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange, workflow management services and telehealth solutions, today announced that Elmora Healthcare, a supplier of home medical equipment, medical supplies and care services, selected Authentidate's Inscrybe® Healthcare web-based service to expedite processing of patient care orders with referring physicians.

16 Mar 2010

Cheetah Medical closes $20M financing round; plans to expand hemodynamic monitoring market

Cheetah Medical, a worldwide leader in noninvasive hemodynamic and cardiac output monitoring technology, announced today the closing of a $20 million financing round. The financing was led by Ascension Health Ventures (AHV) and also included Robert Bosch Venture Capital (RBVC), MVM Life Science Partners (MVM) and existing investors.

16 Mar 2010

Study: Hypoglycemia patients have mortality rate of 36.6%

In a study published in the March issue of Mayo Clinic Proceedings, researchers report that they have found a link between mild to moderate hypoglycemia (low blood sugar) and mortality in critically ill patients.

16 Mar 2010

Senate Parliamentarian Frumin could referee overhaul battle

Senate Parliamentarian Alan Frumin, a veteran master of civil procedure who first joined the office he now leads in 1977, will be center stage if Democrats use a tactic known as budget reconciliation to avoid filibusters as they seek to push through a final health overhaul, The New York Times reports.

16 Mar 2010

Mother's obesity can significantly increase offspring’s susceptibility to obesity

Aspiring moms may be advised to achieve a healthy weight before they become pregnant, and to gain only the recommended amount of weight during their pregnancy

16 Mar 2010

Savient Pharmaceuticals resubmits KRYSTEXXA BLA

Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.

16 Mar 2010

JAOtech opens new U.S. headquarters in Trumbull, Connecticut

JAOtech Ltd. has announced the opening of its U.S. headquarters in Trumbull, Connecticut. The facility serves as JAOtech’s sales, marketing and technical support centre for the United States and Canada. JAOtech Corporation, the company’s wholly owned U.S. subsidiary, has an installed base of more than 13,000 terminals in North America.

16 Mar 2010

President delivers emotional speech, pushes for reform in Ohio

The Associated Press: "With a fresh sense of urgency, President Barack Obama sought to reassure seniors Monday about health care legislation approaching a final vote in Congress, pledging it would make preventive care cost-free and close a gap in Medicare prescription drug coverage. 'This proposal adds almost a decade of solvency to Medicare,' Obama said in a visit to a senior center."

16 Mar 2010

Nuvo Research commences enrollment in WF10 Phase 2 clinical trial for allergic rhinitis

Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.

16 Mar 2010

Positive results from Phase IIa epilepsy study of ICA-105665

Icagen, Inc. today reported positive results in its Phase IIa epilepsy study of ICA-105665, the Company's novel orally available small molecule KCNQ potassium channel agonist.

16 Mar 2010

F1000 adds new Otolaryngology section to support extensive medicine coverage

Faculty of 1000 Biology, the award-winning literature awareness service for the life sciences, has launched the much anticipated Otolaryngology Faculty.

16 Mar 2010

Obama's legacy and democrats' electoral fates tied to overhaul, observers speculate

If Democrats fail to pass health legislation, the loss could have lasting consequences for a president whose supporters have become accustomed to victory, Time writes. "If the President fails to win the upcoming series of congressional votes designed to get health care legislation to his desk, it will be a calamitous failure for his presidency and for him personally, dwarfing the potholes he has hit during his first bumpy year in office.

16 Mar 2010

Aegis Health Group releases PRISM software to help hospital leaders improve physician relationships

Aegis Health Group, the nation's leading healthcare business development company, announces new software to help hospital leaders improve physician relationships, track referral patterns, better manage physician issues, and gain market intelligence. PRISM™, Aegis' proprietary physician relationship management software, is a browser-based database and contact-management program that can be customized to fit the unique needs of each hospital.

16 Mar 2010

FDA approves Watson Pharmaceuticals' ANDA for generic Cardizem LA

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.

16 Mar 2010

Medical News

Dove Medical Press, Athena Healthcare Consultancy enter alliance to publish clinical research

Tel Aviv University researcher uses magic tricks to treat children with locomotor disabilities

Clinton delivers speech at U.N. women's meeting as conference closes

New guidelines to emphasize safety of dental treatment during pregnancy

GAVI calls meeting with existing, potential donors

KHN column: Can incremental health reform provide a path forward?

Elmora Healthcare selects Authentidate's Inscrybe Healthcare for expediting care order processing

Cheetah Medical closes $20M financing round; plans to expand hemodynamic monitoring market

Study: Hypoglycemia patients have mortality rate of 36.6%

Senate Parliamentarian Frumin could referee overhaul battle

Mother's obesity can significantly increase offspring’s susceptibility to obesity

Savient Pharmaceuticals resubmits KRYSTEXXA BLA

JAOtech opens new U.S. headquarters in Trumbull, Connecticut

President delivers emotional speech, pushes for reform in Ohio

Nuvo Research commences enrollment in WF10 Phase 2 clinical trial for allergic rhinitis

Positive results from Phase IIa epilepsy study of ICA-105665

F1000 adds new Otolaryngology section to support extensive medicine coverage

Obama's legacy and democrats' electoral fates tied to overhaul, observers speculate

Aegis Health Group releases PRISM software to help hospital leaders improve physician relationships

FDA approves Watson Pharmaceuticals' ANDA for generic Cardizem LA

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News